RIPK3 expression as a potential predictive and prognostic marker in metastatic colon cancer.
Conev NV, Dimitrova EG, Bogdanova MK, Kashlov YK, Chaushev BG, Radanova MA, Petrov DP, Georgiev KD, Bachvarov CH, Todorov GN, Kalchev KP, Popov HB, Manev RR, Donev IS.
Conev NV, et al. Among authors: kalchev kp.
Clin Invest Med. 2019 Mar 23;42(1):E31-E38. doi: 10.25011/cim.v42i1.32390.
Clin Invest Med. 2019.
PMID: 30904034